Transition from cylindroma to spiradenoma in CYLD‐defective tumours is associated with reduced DKK2 expression

Abstract

Patients carrying heterozygous germline truncating mutations in the CYLD gene develop multiple primary hair follicle-related tumours. A highly patterned tumour, termed cylindroma, and a highly disorganized tumour, termed spiradenoma, may both develop in the same patient. Furthermore, histological features of both tumour types have been described within the same tumour specimen. We used three-dimensional computer-aided reconstruction of these tumours to demonstrate contiguous growth of cylindromas into spiradenomas, thus suggesting a transition between the two tumour types. To explore factors that may influence cutaneous tumour patterning, genome-wide transcriptomic analysis of 32 CYLD-defective tumours was performed. Overexpression of the Wnt/β-catenin signalling pathway was observed relative to normal perilesional tissue. Morphometric analysis was used to investigate the relationship between Wnt pathway-related gene expression and tumour organization. This revealed an association between reduced Dickkopf 2 (DKK2-a negative regulator of the Wnt/β-catenin signalling pathway) expression and loss of tumour patterning. Reduced DKK2 expression was associated with methylation of the DKK2 gene promoter in the majority of tumour samples assayed. RNA interference-mediated silencing of DKK2 expression in cylindroma primary cell cultures caused an increase in colony formation, cell viability, and anchorage-independent growth. Using these data, we propose a model where epigenetic programming may influence tumour patterning in patients with CYLD mutations.

One mutation, two phenotypes: a single nonsense mutation of theCTSCgene causes two clinically distinct phenotypes

“…This phenomenon has also been observed in another group of rare monogenic diseases caused by mutations in the CYLD gene. Initially, Brooke–Spiegler syndrome (BSS; OMIM 605041), multiple familial trichoepithelioma type 1 (MFT1; OMIM 601606) and familial cylindromatosis (FC; OMIM 132700) were considered different entities, until genetic investigation revealed that they were all allelic variants of the same disease …”

Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells

“…Dysfunctional WNT signaling has been associated with a variety of human pathologies (3) affecting different cell types and tissues including several types of cancer, bone diseases, and diseases of the central nervous system. An increasing number of studies suggest that aberrant WNT signaling can be initiated by several mechanisms affecting key elements of the pathway (4–11). For instance, mutations (inactivating mutations on APC or AXIN1 tumor suppressor genes or activating mutations on the β -CATENIN oncogene), autocrine activation (increased expression of pathway components including WNT ligands, FRIZZLED (FZD) receptors and DISHEVELLED (DVL) family members) and epigenetic phenomena (e.g.…”

Infiltrative Recurrent Eccrine Spiradenoma of the Anterior Neck Treated Using Mohs Micrographic Surgery

“…In cases of multiple ES, histology consistent with ES and cylindroma may be found within the same sample, showing overlapping features. We have recently shown that ES may arise from existing cylindromas in Brooke‐Spiegler syndrome …”